Diadexus, Inc. Uncategorized Contracts & Agreements
32 Contracts & Agreements
- Indemnity Agreement (Filed With SEC on August 13, 2015)
- AGREEMENT (Filed With SEC on August 13, 2015)
- AGREEMENT (Filed With SEC on April 20, 2015)
- PURCHASEAGREEMENT KIT PURCHASES (Filed With SEC on November 5, 2013)
- Volume Discount Program Addendum (Filed With SEC on November 7, 2012)
- Rebate Addendum (Filed With SEC on May 10, 2012)
- Volume Discount Addendum No. 2 (Filed With SEC on May 13, 2011)
- Volume Discount Addendum (Filed With SEC on May 13, 2011)
- 2011 Special Programs Addendum (Filed With SEC on May 13, 2011)
- [VAXGEN, INC. LETTERHEAD] (Filed With SEC on March 22, 2011)
- ACKNOWLEDGMENT OF TERM COMMENCEMENT DATE (Filed With SEC on November 15, 2010)
- Addendum No. 2 to the MasterSupply Agreement Dated as of April 1, 2009 (Filed With SEC on November 15, 2010)
- Addendum No. 3 to the DistributionAgreement (Filed With SEC on November 15, 2010)
- Addendum No. 2 to the DistributionAgreement (Filed With SEC on November 15, 2010)
- DISTRIBUTOR AGREEMENT (Filed With SEC on November 15, 2010)
- AGREEMENT BETWEEN (Filed With SEC on November 15, 2010)
- [GSK HEADER] February 28, 2005 (Filed With SEC on November 15, 2010)
- INDEMNITY AGREEMENT (Filed With SEC on November 15, 2010)
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on January 29, 2009)
- Current assets (Filed With SEC on November 10, 2008)
- Current assets (Filed With SEC on May 14, 2008)
- Entry into a Material Definitive Agreement (Filed With SEC on April 1, 2008)
- Entry into a Material Definitive Agreement (Filed With SEC on March 28, 2008)
- Resignation Agreement between VaxGen, Inc and Lance K. Gordon, Ph.D (Filed With SEC on September 20, 2007)
- Surrender Agreement between VaxGen and certain investors, dated December 30, 2004 (Filed With SEC on February 7, 2007)
- Agreement by and between VaxGen and Celltrion pursuant to which VaxGen acquired all of Celltrions interest in VaxGen-Celltrion, Inc., dated December 30, 2004 (Filed With SEC on February 7, 2007)
- SALARIES OF NAMED EXECUTIVE OFFICERS (Filed With SEC on October 26, 2006)
- FORM OF INDEMNITY AGREEMENT (Filed With SEC on October 26, 2006)
- AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT (Filed With SEC on May 11, 2006)
- [VaxGen Letterhead] (Filed With SEC on June 6, 2005)
- VACCINE ADVERSE EVENT REPORTING SYSTEM 24 Hour Toll Free Information ###-###-#### P.O. Box 1100, Rockville, MD 20849-1100 PATIENT IDENTITY KEPT CONFIDENTIAL (Filed With SEC on March 30, 2004)
- AWARD/CONTRACT (Filed With SEC on November 19, 2003)
